Eurobio Scientific UK
Eurobio Scientific UK
Eurobio Scientific UK will be exhibiting at ABS Conference 2026, showcasing EndoPredict® - a genomic breast cancer test used in ER-positive, HER2-negative early breast cancer to support recurrence risk assessment and chemotherapy decision-making. We will also be highlighting Prolaris®, a molecular prostate cancer test designed to help assess tumour aggressiveness and support treatment decisions in localised prostate cancer.
Eurobio Scientific supports NHS and private laboratories across the UK & Ireland with specialist diagnostic solutions across oncology, transplantation, infectious disease and blood sciences.
Pharmaceutical companies have solely provided sponsorship for the ABS Conference 2026 through the purchase of exhibition space and/ or sponsored symposia and have had no further input into the arrangements or programme for the event. See the list of sponsors.
